The role of mesenchymal stem cell-derived EVs in diabetic wound healing

Min Jiang1, Xupin Jiang1, Hongmei Li2

  • 1Department of Plastic Surgery, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.

Insights

Mesenchymal stem cell-derived extracellular vesicles (EVs) show promise for accelerating diabetic wound healing. These EVs offer a safer alternative to stem cell transplantation for treating diabetic foot complications.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Diabetes Research

Background:

  • Diabetic foot ulcers are a severe diabetes complication, often necessitating surgery and amputation.
  • Current treatments for diabetic foot wounds are limited, driving the need for novel therapeutic strategies.
  • Stem cell transplantation shows potential for wound healing but faces safety and clinical application challenges.

Purpose of the Study:

  • To review the current understanding of mesenchymal stem cell-derived extracellular vesicles (EVs) in promoting diabetic wound healing.
  • To explore the potential clinical applications of these EVs as a therapeutic approach.

Main Methods:

  • Literature review of studies on mesenchymal stem cell (MSC) derivatives and diabetic wound healing.
  • Analysis of the composition and function of extracellular vesicles (EVs).
  • Evaluation of the safety profile and therapeutic advantages of EVs compared to parental stem cells.

Main Results:

  • Mesenchymal stem cell (MSC) efficacy in wound healing is increasingly linked to their secreted EVs.
  • EVs facilitate intercellular communication through their cargo of RNA, DNA, and proteins.
  • EVs present a superior safety profile, avoiding immune responses, ethical concerns, and risks like embolism and carcinogenesis.

Conclusions:

  • Mesenchymal stem cell-derived EVs represent a promising cell-free therapeutic strategy for accelerating diabetic wound healing.
  • The inherent safety and efficacy of EVs warrant further investigation for clinical translation in managing diabetic foot complications.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.1K